Current and Emerging Therapeutics for Cutaneous T-Cell Lymphoma: Histone Deacetylase Inhibitors

Table 2

Bunn and Lambert system. This stage classification uses the TMN staging system to subclassify the clinical disease progression.

Stage IA	T1 N0 M0
Stage IIB	T2 N0 M0
Stage IIA	T1/2 N1 M0
Stage IIB	T3 N0/1 M0
Stage III	T4 N0/1 M0
Stage IVA	T1–4 N2/3 M0
Stage IVB	T1–4 N0-3 M1